Delivery Order SPE2DB22D3016-SPE2DB25FAYS7
Award Date
6/9/25
Potential Completion Date
7/1/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $119,604.20 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the provision of DARZALEX FASPRO, a medication used in the treatment of certain blood cancers. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,920.84 contract is for the supply of DARZALEX FASPRO, a medication used in the treatment of certain blood cancers. The contract has a performance period ending on May 20, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a $143,525.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO, a 1,800mg/30,000 15ml pharmaceutical product, with a completion date of July 1, 2025. The order is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DARZALEX FASPRO, a medication used to treat certain types of cancer. The contract has a ceiling value of $47,841.68 and is a firm fixed-price, non-set-aside contract with a performance period through May 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $122,573.56 contract is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical product, by June 18, 2025. The award is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,960.42, is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical product, to the federal government. The contract is a firm fixed-price, non-set-aside award with a period of performance through July 3, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,881.26, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp is the prime contractor and there are no subcontractors mentioned. This contract is not...
This is a $107,355.20 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product, with a performance period through January 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) awarded a $35,881.26 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 30,000 units of the specialty drug DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 3, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a firm fixed price of $11,040.84 and an ultimate completion date of December 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...